Advances in pluripotent stem cells: history, mechanisms, technologies, and applications
G Liu, BT David, M Trawczynski, RG Fessler - Stem cell reviews and …, 2020 - Springer
Over the past 20 years, and particularly in the last decade, significant developmental
milestones have driven basic, translational, and clinical advances in the field of stem cell …
milestones have driven basic, translational, and clinical advances in the field of stem cell …
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in …
P Godoy, NJ Hewitt, U Albrecht, ME Andersen… - Archives of …, 2013 - Springer
This review encompasses the most important advances in liver functions and hepatotoxicity
and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested …
and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested …
A comparison of non-integrating reprogramming methods
TM Schlaeger, L Daheron, TR Brickler, S Entwisle… - Nature …, 2015 - nature.com
Human induced pluripotent stem cells (hiPSCs,,) are useful in disease modeling and drug
discovery, and they promise to provide a new generation of cell-based therapeutics. To date …
discovery, and they promise to provide a new generation of cell-based therapeutics. To date …
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells
K Okita, T Yamakawa, Y Matsumura, Y Sato… - Stem …, 2013 - academic.oup.com
The generation of induced pluripotent stem cells (iPSCs) provides the opportunity to use
patient-specific somatic cells, which are a valuable source for disease modeling and drug …
patient-specific somatic cells, which are a valuable source for disease modeling and drug …
Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
H Ban, N Nishishita, N Fusaki… - Proceedings of the …, 2011 - National Acad Sciences
After the first report of induced pluripotent stem cells (iPSCs), considerable efforts have been
made to develop more efficient methods for generating iPSCs without foreign gene …
made to develop more efficient methods for generating iPSCs without foreign gene …
Generation of induced pluripotent stem cells from urine
T Zhou, C Benda, S Duzinger, Y Huang… - Journal of the …, 2011 - journals.lww.com
Forced expression of selected transcription factors can transform somatic cells into
embryonic stem cell (ESC)-like cells, termed induced pluripotent stem cells (iPSCs). There is …
embryonic stem cell (ESC)-like cells, termed induced pluripotent stem cells (iPSCs). There is …
HIF1α Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1–3 and PKM2
A Prigione, N Rohwer, S Hoffmann, B Mlody… - Stem …, 2014 - academic.oup.com
Reprogramming somatic cells to a pluripotent state drastically reconfigures the cellular
anabolic requirements, thus potentially inducing cancer-like metabolic transformation …
anabolic requirements, thus potentially inducing cancer-like metabolic transformation …
Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells
PW Burridge, A Holmström… - Current protocols in human …, 2015 - Wiley Online Library
Since the first discovery that human pluripotent stem cells (hPS cells) can differentiate to
cardiomyocytes, efforts have been made to optimize the conditions under which this process …
cardiomyocytes, efforts have been made to optimize the conditions under which this process …
CPAP promotes timely cilium disassembly to maintain neural progenitor pool
E Gabriel, A Wason, A Ramani, LM Gooi, P Keller… - The EMBO …, 2016 - embopress.org
A mutation in the centrosomal‐P4. 1‐associated protein (CPAP) causes Seckel syndrome
with microcephaly, which is suggested to arise from a decline in neural progenitor cells …
with microcephaly, which is suggested to arise from a decline in neural progenitor cells …
Abnormal RNA stability in amyotrophic lateral sclerosis
EM Tank, C Figueroa-Romero, LM Hinder… - Nature …, 2018 - nature.com
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share key features,
including accumulation of the RNA-binding protein TDP-43. TDP-43 regulates RNA …
including accumulation of the RNA-binding protein TDP-43. TDP-43 regulates RNA …